Fmoc-N-methyl-O-benzyl-L-serine, 97%, 10g

2,4-Dichlorobenzene-1,3-diol, 95.0%, 10g

6-CHLOROQUINOLINE-4-CARBOXYLIC ACID, 95.0%, 100mg

2-(4-(4-METHOXYBENZOYL)PIPERIDIN-1-YL)ACETIC ACID, 95.0%, 1g

5-Bromo-2-methyl-3-nitrobenzoic acid, 95.0%, 5g

monoclonal de souris anti-DDDDK-tag, AP1501, 25 µg

3-(4-Trifluoromethyl-pyridin-2-yl)-benzoic acid, 95.0%, 5g

Methyl 2-((3S,4R)-4-aminopyrrolidin-3-yl)acetate bis(4-methylbenzenesulfonate), 95%, 1g

(S)-2-((S)-2-AMINO-3-METHYLBUTANAMIDO)-3-(4-HYDROXYPHENYL)PROPANOIC ACID, 95%, 1g

A-779>97.0%(HPLC)25mg

5-Bromo-6-(trifluoromethyl)pyrimidin-4-amine, 98%, 250mg

5-Bromo-2-phenyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

2-Chloro-3-fluorobenzaldehyde, 98.0%, 500g